文献速递血栓与止血

肝素诱导的血小板减少症中与致病性抗体结合的血小板因子4氨基酸特征分析

Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2019-01-01

本研究采用丙氨酸扫描诱变产生70个血小板因子4(PF4)单点突变体,通过酶免疫分析检测其与血小板活化鼠单克隆抗PF4/肝素抗体(KKO)及9例肝素诱导的血小板减少症(HIT)患者血清的结合能力。鉴定出13个对KKO结合必需的氨基酸、10个对HIT患者血清结合必需的氨基酸,其中5个为两者共同必需;进一步在45例致病性抗体和28例非致病性抗体中鉴定出5个PF4突变对致病性HIT抗体结合必需。

要点

  • 丙氨酸扫描诱变产生70个PF4单点突变体,用于定位HIT抗体结合位点。
  • 13个氨基酸直接影响KKO结合位点或PF4抗原构象,其中3个为新发现。
  • 5个PF4氨基酸有助于区分致病性与非致病性抗体。

核心结论

  • 利用丙氨酸扫描诱变表征了致病性HIT抗体在PF4上的可能结合位点。

研究设计与样本

  • 采用丙氨酸扫描诱变产生70个血小板因子4(PF4)单点突变体,每个突变体用于酶免疫分析(EIA)检测其与血小板活化鼠单克隆抗PF4/肝素抗体(KKO)及HIT患者血清(n=9)的结合能力。

主要发现

  • 鉴定出13个对KKO结合必需的氨基酸,因其直接影响结合位点或PF4抗原构象,其中3个为新发现。
  • 鉴定出10个对HIT患者血清结合必需的氨基酸,其中5个为KKO和HIT患者血清结合共同必需。
  • 对HIT血清结合必需的10个氨基酸进一步在致病性HIT抗体(血小板活化,n=45)和非致病性抗体(EIA阳性但无血小板活化,n=28)中测试,鉴定出5个PF4突变对致病性HIT抗体结合必需。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Essentials Many patients produce antibodies but few lead to heparin-induced thrombocytopenia (HIT). Pathogenic epitopes are difficult to identify as HIT antibodies are polyclonal and polyspecific. KKO binding to platelet factor 4 (PF4) depends on 13 amino acids, three of which are newly observed. Five amino acids in PF4 can help distinguish pathogenic from non-pathogenic antibodies. SUMMARY: Background Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction that results in thrombocytopenia and, in some patients, thrombotic complications. HIT is mediated by antibodies that bind to complexes of platelet factor 4 (PF4) and heparin. The antigenic epitopes of these anti-PF4/heparin antibodies have not yet been precisely defined, because of the polyspecific immune response that characterizes HIT. Objectives To identify PF4 amino acids essential for binding pathogenic HIT antibodies. Methods Alanine scanning mutagenesis was utilized to produce 70 single point mutations of PF4. Each PF4 mutant was used in an enzyme immunoassay (EIA) to test their capacity to bind a platelet-activating murine monoclonal anti-PF4/heparin antibody (KKO) and HIT patient sera (n = 9). Results and Conclusions We identified 13 amino acids that were essential for binding KKO because they directly affected either the binding site or the antigenic conformation of PF4. We also identified 10 amino acids that were required for the binding of HIT patient sera and five of these amino acids were required for binding both KKO and the HIT patient sera. The 10 amino acids required for binding HIT sera were further tested to differentiate pathogenic HIT antibodies (platelet activating, n = 45) and non-pathogenic antibodies (EIA-positive but not platelet activating, n = 28). We identified five mutations of PF4 that were recognized to be essential for binding pathogenic HIT antibodies. Using alanine scanning mutagenesis, we characterized possible binding sites of pathogenic HIT antibodies on PF4.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Huynh A, Arnold DM, Kelton JG, et al. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia. J Thromb Haemost. 2019. PMID: 30582672. doi:10.1111/jth.14369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。